Skip to main content

Nasdaq Markets

Rule Breaker Investing Over 15 Years

6 years ago
In this episode of Rule Breaker Investing: Essays from Yesterday, Vol. 2, Motley Fool co-founder David Gardner talks about some interesting companies, recommendations, trends, and technological innovations spanning over 15 years. He also discusses what lessons they hold for inve

Why Loop Industries Dropped Again Today

6 years ago
What happened Following a huge 33% drop yesterday, shares of Loop Industries (NASDAQ: LOOP) were off another 14% today before recovering later in the day. As of 3:20 p.m. EDT, shares are still down by about 5%.

Will Earnings Reports Drive Shares This Earnings Season?

6 years ago
Yesterday was the first big day this earnings season, with companies like Johnson & Johnson JNJ, JPMorgan Chase JPM, Citigroup C, Blackrock BLK, Wipro Ltd. WIT, Delta Air Lines DAL, First Republic Bank FRC and many others reporting results. And although there were some reall

Swiss Market Ends Weak Again

6 years ago
(RTTNews) - The Switzerland stock market failed to hold early gains and ended moderately lower on Wednesday as worries about rising coronavirus cases weighed on sentiment.

Why Kandi Technologies Stock Just Popped 7.5%

6 years ago
What happened Chinese electric-vehicle maker Kandi Technologies (NASDAQ: KNDI) got off to an inauspicious start in August, when its "live virtual launch" of two new electric car models (the K23 and K27) netted the company only 11,000 registrations to view the event online -- and

Why Navistar Stock Just Dropped 18.5%

6 years ago
What happened All year long, Germany's Volkswagen (OTC: VWAGY) has been trying to buy America's Navistar International (NYSE: NAV) truck company in an international merger. In January, Volkswagen offered to pay $35 for each outstanding share, sending Navistar stock soaring. Then

Why Cyclerion Therapeutics Is Crashing Today

6 years ago
What happened Shares of clinical-stage biotech Cyclerion Therapeutics (NASDAQ: CYCN) are down by an eye-popping 48% as of noon EDT Wednesday. The small-cap biotech's stock is crashing in response to a negative midstage trial result for its sickle cell disease candidate olincigua
Checked
29 minutes 45 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed